Spoc Proteomics Inc.
Scottsdale, AZ Doing business as Inanobio
- UEI
- QA7ENLFWNZW9
- CAGE
- 7FXG2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 7201 E Henkel Way #285, Scottsdale, AZ 85255, USA
- Website
- spoc.bio
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Icahn School Of Medicine At Mount Sinai | N6600119C4022 | $1,605,208 |
Grant awards
Similar vendors
About the company
Spoc Proteomics Inc., doing business as INanoBio, is a nano biotechnology company based in Phoenix, Arizona that develops transformative nano biotechnology platforms and machine learning for high accuracy early stage disease diagnostics. The company is registered as a corporate entity, minority-owned business, for-profit organization and Subcontinent Asian (Asian-Indian) American-owned.
Through federal contract awards, Spoc Proteomics Inc. has developed a solid-state FENT nanopore transistor module for high-speed, accurate molecular detection as part of the Epigenetic CHaracterization and Observation (ECHO) program. The goal of this program is to utilize an individual's epigenome to reveal their history of exposure to weapons of mass destruction and precursors. Spoc Proteomics Inc. has worked as a subcontractor to the Icahn School of Medicine at Mount Sinai on tasks such as developing bioinformatics algorithms to identify epigenetic exposure-specific signatures and a field-deployable platform for diagnosing biothreat exposures and infections. The company has also conducted market analysis, regulatory assessments, and engaged with potential strategic partners for transitioning its ECHODAR device.
Through federal grant awards from the National Institutes of Health's National Center for Advancing Translational Sciences, Spoc Proteomics Inc. has developed a novel Sensor Integrated Proteome on Chip (SPOC) platform that combines in situ expression and capture of functional proteins on biosensors for high-throughput analysis of protein interactions in real-time. The company has integrated the SPOC platform with Surface Plasmon Resonance Imaging (SPRI) to create an integrated ProSPR instrument for determining kinetic information of protein biomolecular interactions. Additionally, Spoc Proteomics Inc. has developed a Chemical Reaction Sensor Array Platform for label-free, real-time kinetic analysis of enzyme-substrate reactions to enable high-throughput drug discovery.
Quick answers
Is Spoc Proteomics Inc. registered in SAM.gov?
Yes. Spoc Proteomics Inc.'s SAM.gov registration is active through June 8, 2027.
What is Spoc Proteomics Inc.'s most recent federal award?
Spoc Proteomics Inc.'s most recent federal grant award is Novel sensor integrated proteome on chip (spoc) platform for evaluating kinetic parameters of protein interactions in… (R44TR004297), from National Center for Advancing Translational Sciences (NIH), on August 12, 2022.
On GovTribe
See Spoc Proteomics Inc.'s full federal record
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors